Website claims and GMP violations continue to dominate FDA warning letters
date:May 12, 2012
ever, FDA deemed that SEIs response was inadequate on a number of points.


Commenting on the warning letter, the American Herbal Products Association (AHPA) said that the letter reminds industry that a Form 483 response to FDA that says we are going to fix it is not enough, FDA wants to be shown the fix.

05/03 17:32